The intra-tumoral heterogeneity in glioblastoma : a limitation for prognostic value of epigenetic markers?

Abstract

Objective Epigenetic tumor features are getting into focus as prognostic markers in glioblastoma. Whether intra-tumoral heterogeneity in these epigenetic characteristics may infuence prognostic value remains unclear. Methods Of 154 patients sufering from glioblastoma, 120 patients served as reference collective, while 34 patients were compiled as test collective. MGMT, p15, and p16 promoter methylation and miRNA expression levels (miRNA-21, miRNA24, miRNA-26a, and miRNA-181d) were measured in each tumor specimen. Serving as a statistical baseline, epigenetic heterogeneity between tumors (inter-tumoral) was estimated within a triplet of three tumor specimens from three diferent reference patients. For estimation of epigenetic heterogeneity within a tumor (intra-tumoral), previous results were compared to three tumor specimens within one glioblastoma of patients of the test collective. Resulting levels of heterogeneity were then correlated with survival and validated by an external TCGA data set. Results Heterogeneity in MGMT promoter methylation occurred less likely in the test group compared to the reference group. No diference in heterogeneity was observed between test and reference group regarding p15 and p16 methylation. Intratumoral heterogeneity within the test group regarding miRNA-21, miRNA-24, miRNA-26a, and miRNA-181d expression was not distinguishable from inter-tumoral heterogeneity. A homogenously increased miRNA-21 expression was associated with reduced overall survival in the test collective. The fndings could be validated by comparison with TCGA datasets. Conclusion Heterogeneity of epigenetic characteristics in one glioblastoma may be of the same magnitude as heterogeneity between diferent patients. Not only the extent of epigenetic characteristics but also the extent of intra-tumoral heterogeneity may infuence survival in glioblastoma.